Table 3.

The difference of baseline parameters between favorable and unfavorable renal outcome at 6 months

	Favorable renal outcome (n = 53)	Unfavorable renal outcome (n = 70)	P value
Plasma cf-mtDNA (GE/mL)	441.1 ± 525.6	370.6 ± 641.9	0.538
Plasma cf-nDNA (GE/mL)	760.9 ± 732.9	554.1 ± 850.9	0.184
Urine cf-mtDNA (GE/mL)	0.489 ± 0.751	3.745 ± 12.197	0.027*
Urine cf-nDNA (GE/mL)	1.764 ± 2.388	15.119 ± 40.791	0.009*
MCN (per cell)	87.21 ± 69.40	101.55 ± 95.75	0.356
Urine 8-OH dG/Cr	3.62 ± 2.44	4.03 ± 2.44	0.346
NGAL (ng/mL)	585.24 ± 251.62	780.85 ± 391.39	0.032*

*P < 0.05, Student’s test

MCN, mitochondrial copy number; NGAL, neutrophil gelatinase-associated lipocalin; 8-OH dG, 8-hydroxy-2-deoxyguanosine; cf-mtDNA, cell-free mitochondrial DNA; cf-nDNA, cell-free nuclear DNA; GE/mL, genome equivalents /mL

Favorable renal outcome indicated eGFR at 6 months minus baseline eGFR> = 0; unfavorable renal outcome indicated eGFR at 6 months minus baseline eGFR <0